Levo-corydalmine attenuates microglia activation and neuropathic pain by suppressing ASK1-p38 MAPK/NF-κB signaling pathways in rat spinal cord
WL Dai, YN Bao, JF Fan, SS Li, WL Zhao… - Regional Anesthesia & …, 2020 - rapm.bmj.com
Background and objectives Neuropathic pain is partially refractory to currently available
treatments. Although some studies have reported that apoptosis signal-regulating kinase 1 …
treatments. Although some studies have reported that apoptosis signal-regulating kinase 1 …
Levo-corydalmine attenuates microglia activation and neuropathic pain by suppressing ASK1-p38 MAPK/NF-κB signaling pathways in rat spinal cord
D Wen-Ling, B Yi-Ni, JF Fan… - … and Pain Medicine, 2020 - search.proquest.com
Methods Chronic constriction injury (CCI) of the rat sciatic nerve was used to establish a
neuropathic pain model. Nociception was assessed using von Frey hair and Hargreaves' …
neuropathic pain model. Nociception was assessed using von Frey hair and Hargreaves' …
Levo-corydalmine attenuates microglia activation and neuropathic pain by suppressing ASK1-p38 MAPK/NF-κB signaling pathways in rat spinal cord
WL Dai, YN Bao, JF Fan, SS Li… - … and pain medicine, 2020 - pubmed.ncbi.nlm.nih.gov
Background and objectives Neuropathic pain is partially refractory to currently available
treatments. Although some studies have reported that apoptosis signal-regulating kinase 1 …
treatments. Although some studies have reported that apoptosis signal-regulating kinase 1 …
[PDF][PDF] Levo-corydalmine attenuates microglia activation and neuropathic pain by suppressing ASK1-p38 MAPK/NF-κB signaling pathways in rat spinal cord
WL Dai, YN Bao, JF Fan, SS Li, WL Zhao, BY Yu… - researchgate.net
AbsTrACT background and objectives Neuropathic pain is partially refractory to currently
available treatments. Although some studies have reported that apoptosis signal-regulating …
available treatments. Although some studies have reported that apoptosis signal-regulating …
Levo-corydalmine attenuates microglia activation and neuropathic pain by suppressing ASK1-p38 MAPK/NF-κB signaling pathways in rat spinal cord
WL Dai, YN Bao, JF Fan, SS Li, WL Zhao… - Regional Anesthesia & …, 2020 - rapm.bmj.com
Background and objectives Neuropathic pain is partially refractory to currently available
treatments. Although some studies have reported that apoptosis signal-regulating kinase 1 …
treatments. Although some studies have reported that apoptosis signal-regulating kinase 1 …
Levo-corydalmine attenuates microglia activation and neuropathic pain by suppressing ASK1-p38 MAPK/NF-κB signaling pathways in rat spinal cord.
WL Dai, YN Bao, JF Fan, SS Li, WL Zhao… - … Anesthesia and Pain …, 2020 - europepmc.org
Methods Chronic constriction injury (CCI) of the rat sciatic nerve was used to establish a
neuropathic pain model. Nociception was assessed using von Frey hair and Hargreaves' …
neuropathic pain model. Nociception was assessed using von Frey hair and Hargreaves' …